维普期刊资源整合服务平台（V6.5）

66篇 您的检索式：作者名="Massy Z"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Beta2 - microglobulin 显示文摘	Drueke T B Massy Z A	2009	Semin Dial2009，22，4：	1
2	Chronic Renal Allograft Rejection:Immunologic and Nonimmunologic Risk Factors显示文摘	Massy Z A Guijarro C Wiederkehr M R	1996	Kidney Int1996，49，：	1
3	Sustained reduction of hyperhomocysteinaemia with folic acid supplementation in predialysis patients显示文摘	Jungers P Joly D Massy Z	1999	Nephrol Dial Transplant1999，14，12：	1
4	Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study显示文摘	JUNGERS P MASSY Z A KHOA T N	1997	Nephrol Dial Transplant1997，12，2：	1
5	Chronic kidney disease as cause of cardiovascular morbidity and mortality 显示文摘	Vanholder R Massy Z Argiles A	2005	Nephrol Dial Transplant2005，20，6：	1
6	Beta2-microglobulin 显示文摘	Drueke T B Massy Z A	2009	Semin Dial2009，22，4：	1
7	Iron therapy, advanced oxidation protein products, and carotid artery intimamedia thickness in end-stage renal disease 显示文摘	Drueke T Witko-Sarsat V Massy Z	2002	Circulation2002，106，17：	1
8	Monocyte sub- populations and cardiovascular risk in chronic kidney disease显示文摘	Heine G H Ortiz A Massy Z A	2012	Nat Rev Nephrol2012，8，6：	1
9	miR- 143 and miR-145 : molecular keys to switch the phenotype of vas- cular smooth muscle cells 显示文摘	Rangrez A Y Massy Z A Metzinger-Le Meuth V	2011	Cite Cardiovasc Genet2011，4，2：	1
10	Oxidative Stress and Haemodialysis:Role of Inflammation and Duration of Dialysis Treatment显示文摘	NGUYEN-Khoa T MASSY Z A DE BANDT J P	2001	Nephrol Dial Transp lant2001，16，：	1
11	Chronic kidney disease as cause of cardiovascular morbidity and mortality 显示文摘	VANHOLDER R MASSY Z ARGILES A	2005	Nephrol Dial Transpl2005，20，6：	1
12	Chronic kid-ney disease as cause of cardiovascular morbidity andmortality显示文摘	Vanholder R Massy Z Argiles A el al	2005	Nephrol Dial Transplant2005，20，6：	1
13	Low-density lipoprotein-induced expression of interleukin-6, a marker of human mesangial cell inflammation: effects of oxidation and modulation by lovastatin显示文摘	Massy Z A Kim Y Guijarro C	2000	Biochem Biophys Res Commun2000，267，：	1
14	Chronic kidney disease as cause of cardiovascular morbidity and mortality显示文摘	VANHOLDER R MASSY Z VARGILES A	2005	Nephrol Dial Transplant2005，20，：	1
15	Chronic kidney disease as cause of cardiovascular morbidity and mortality 显示文摘	Vanholder R Massy Z Argiles A	2005	Nephrol Dial Transplant2005，20，6：	1
16	Homocystine oxidative stress and endothelium function in uremic patients显示文摘	Massy Z A Ceballos I Chadefaux-vekemens B	2001	Kidney Iat(Suppl)2001，78，：	1
17	Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease 显示文摘	Drueke T Witko-Sarsat V Massy Z	2002	Circulation2002，106，17：	1
18	Is iron a culprit in oxidative stress显示文摘	Massy Z A	2003	Blood Purif2003，21，3：	1
19	Chronic kidneydisease as cause of cardiovascular morbidity and mortality显示文摘	Vanholder R Massy Z Argiles A	2005	Nephrol Dial Transplant2005，20，：	1
20	Low-density lipoprotein-induced expression of interleukin-6, a marker of human mesangial cell inflammation: effects of oxidation and modulation by lovastatin显示文摘	Massy Z A Kim Y Guijarro C	2000	Biochem Biophys Res Commun2000，267，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示